LENEXA, Kan., May 2, 2006 (PRIMEZONE) -- Mediware Information Systems (Nasdaq:MEDW) announces today that Tarzana Treatment Centers has successfully deployed Mediware's integrated suite of Medication Management solutions -- WORx(r), MediMAR(r) and MediCOE(tm). Mediware's solutions enable Tarzana Treatment Centers to unify its medication delivery protocol by bringing the physician, pharmacist and nurse together for medication orders through administration to the patient.
Tarzana Treatment Centers are a non-profit organization, providing a range of services for adult, teens and youth for medication detoxification, residential rehabilitation treatment, substance abuse, outpatient services and mental health treatment. Tarzana Treatment Centers are a new client profile for Mediware, yet progressive and forward thinking with the same drive to improve safety and care quality.
"We looked closely at several systems before choosing Mediware. Their Medication Management suite allows us to accomplish a number of important goals. First, it offers us the safest possible medication environment for our clients. Second, it helps our staff by reducing the amount of manual documentation they need and finally, it helps us manage our business by giving us easy access to information about our drug costs and drug utilization that we have not had before." -- Albert Senella, Chief Operating Officer, Tarzana Treatment Centers.
Through the use of Mediware's integrated suite of medication management solutions, Tarzana achieves many objectives. "Our implementation of Mediware's closed-loop medication solution is just the most recent example of our ongoing commitment to provide the best possible treatment to our clients. It also continues a 30 year legacy of leadership that Tarzana Treatment Centers has shown to our industry." -- Scott Taylor, CEO and Chairman of the Board of Tarzana Treatment Centers.
"We are excited about Tarzana and are committed to their vision and long-term success. Their experience validates the clinical, operational and financial benefits of our fully integrated medication management suite in the behavioral health marketplace." -- Kevin Ketzel, Vice President and General Manager of Mediware's Medication Management Division.
Mediware delivers an integrated and comprehensive solution that helps ensure safety at every touch point of the medication management process. The closed-loop medication solutions help healthcare organizations create a complete medication safety strategy to reduce errors at every step where they can occur -- prescribing, transcribing, administering, dispensing and monitoring.
About Tarzana Treatment Centers
Founded in 1972, Tarzana Treatment Centers, Inc. is a full-service behavioral healthcare organization that provides high quality, cost-effective substance abuse and mental health treatment to adults and youths. They are a non-profit, community-based organization that operates a psychiatric hospital, residential and outpatient treatment centers and family medical clinics. All facilities are licensed and certified by the State of California and the County of Los Angeles and are accredited by the Joint Commission on Accreditation of Healthcare Organizations (JCAHO).
About Mediware
Mediware delivers powerful software solutions that encapsulate patient care instructions, reinforce patient safety practices and improve efficiencies to lower costs. Mediware targets three primary areas of patient care -- Medication Management, Perioperative management and Blood transfusion, inventory and donor practices -- with specialized solutions that are proven in more than 1,000 client installations. Mediware's customers include prestigious hospitals, clinics, correctional institutions, blood centers and other public and private health care institutions throughout the world. For more information about Mediware products and services, visit our web site at www.mediware.com.
Certain statements in this press release may constitute "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995, as the same may be amended from time to time (the "Act") and in releases made by the SEC from time to time. Such forward-looking statements are not based on historical facts and involve known and unknown risks, uncertainties and other factors disclosed in the Company's Annual Report on Form 10-K for the year ended June 30, 2005, which may cause the actual results of the Company to be materially different from any future results expressed or implied by such forward-looking statements. The Company disclaims any obligation to update its forward-looking statements.